News and Events

First Products Shipped to Labcon North America

Original ASX Announcement: http://www.asx.com.au/asxpdf/20170621/pdf/43k2cwl5wjpy1s.pdf Highlights First products shipped to Labcon North America under agreement signed April 2017. Labcon commence tooling for manufacture Significant acceleration of annual revenue growth expected in FY18. Capital raise $2.53m, 1:3 non‑renounceable rights issue and shortfall placement to support growth and working capital. Notice of allowance to patent for ‘Temperature Sensing and …

Rights Issue Offer Documentation

Highlights: Non‑renounceable rights issue of 1 Share for every 3 Shares held at an issue price of $0.028 per New Share to raise up to $2.53 million (before costs) made pursuant to section s.708AA(2) Corporations Act 2001. Eligible Shareholders may also apply for additional New Shares in excess of their full entitlement that are not …

Bluechiip featured in the TechInvest online

BLUECHIIP THRIVES IN EXTREME TIMES “Millions of parents worldwide have benefited from InVitro Fertilisation (IVF) technology, which has enabled them to conceive happy, healthy babies” Click on the link below to go to the original article: Bluechiip thrives in extreme times  

Open Briefing interview with MD/CEO Andrew McLellan

  Melbourne, April 27, 2017 AEST Bluechiip Ltd (ASX:BCT) is pleased to provide the script of the Open Briefing interview with the MD/CEO Andrew McLellan. In this Open Briefing(R), Andrew discusses: – Labcon OEM agreement – Sales and developer kit pipeline – Genea Biomedx and Planet Innovation progress – Working capital openbriefing.com 1. Andrew, Bluechiip …

Major agreement signed with Labcon North America

Major agreement signed with Labcon North America   Key points: Bluechiip enters third major supply and license agreement – the first in North America. Technology access fee with upfront and ongoing fees over the next 18 months. Bluechiip Limited [ASX:BCT], a leader in the development of sample tracking technology for harsh environments, today announced it …

Bluechiip will be exhibiting in ISBER annual meeting in Toronto, Canada. May 9th to 12th 2017

Bluechiip will be present in booth #511 in the annual International Society for Biological and Environmental Repositories in Toronto, ON, Canada that will take place on the 10th and 12th of May 2017. ISBER 2017 Annual Meeting & Exhibitions ISBER is a global biobanking organization which creates opportunities for networking, education, and innovations and harmonizes …

Bluechiip will be exhibiting in the 10th Australasian Gene and Cell Therapy Society (AGCTS) and Australasian Society for Stem Cell Research (ASSCR) Scientific Meeting. Sydney 24th to 26th of May 2017

Bluechiip will be sponsoring and exhibiting in the 10th Australasian Gene and Cell Therapy Society (AGCTS) and Australasian Society for Stem Cell Research (ASSCR) Scientific Meeting – 24th to 26th of May 2017 in Sydney (Aerial Function Centre, University of Technology). 10th AGCTS & ASSCR Meeting This conference brings together local, national, and international experts, …

The Aus Synchrotron validates Bluechiip technology and helps create a product for pharma research #cryopin

The Australian has published today 30th of January 2017 an article about the successful collaboration between the Australian Synchrotron and Bluechiip. The partnership started two years ago with scientists in the Aus Synchrotron providing input to design a new Bluechiip tag packaging and antenna to be incorporated in the sample holders for protein chrystallography diffraction. …